Congo spy informant dies while on trial for U.N. experts’ killing
An informant for Congo’s intelligence agency who was on trial for alleged involvement in the murders of two U.N. investigators has died from a long-term...
Protests snarl public transportation in Chile, death toll hits 15
A hobbled metro system and damage to downtown streets snarled public transportation in the Chilean capital Santiago on Tuesday, following days of protests throughout the...
Kenya launches first breast milk bank to help newborns
The five mothers sat in a bright blue room in Kenya’s largest maternity hospital waiting to pump breast milk – but not for their own...
Mozambique’s Nyusi heads for big win as poll irregularities reported
Mozambique’s President Filipe Nyusi was on Tuesday forecast to be heading for a landslide victory in an election the opposition says has been tarnished by...
Indonesia’s Indrawati to stay on as finance minister, cheering rupiah
Indonesian Finance Minister Sri Mulyani Indrawati said on Tuesday she had been asked by President Joko Widodo to stay in her post in his new...
Climate change hampers progress on fighting epidemics: Global Fund
Climate change is making it harder to eradicate deadly epidemics, with rising temperatures helping mosquitoes spread malaria in higher places in Africa, the head of...
Guinea protest leaders sentenced to jail for organizing against president
Five opposition and civil society leaders in Guinea were convicted and sentenced to prison on Monday for organizing protests against a possible change to the...
India government, Facebook spar over decryption laws at top court
India’s government asked Facebook Inc on Tuesday to help it decrypt private messages on its network, citing national security requirements in a court hearing on...
DRC president visits deadly bus crash site
At least 30 people died in a bus crash in the Democratic Republic of Congo on Sunday. President Felix Tshisekedi visited suvivors on Monday. Anna...
Bristol-Myers’ immunotherapies show promise in lung cancer trial; shares rise
Bristol-Myers Squibb Co said on Tuesday an interim analysis of a late-stage trial testing a combination of its immuno-oncology drugs Opdivo and Yervoy met the...